Vontobel Holding
AVIR icon

Vontobel Holding’s Atea Pharmaceuticals AVIR Stock Holding History

Vontobel Holding’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-600,461
Closed -$1.8M – 1111
2023
Q3 		$1.8M Buy
600,461
+98,924
+20% +$337K 0.02% 449
2023
Q2 		$1.88M Buy
501,537
+120,687
+32% +$452K 0.02% 453
2023
Q1 		$1.28M Buy
380,850
+99,447
+35% +$403K 0.01% 523
2022
Q4 		$1.35M Buy
+281,403
New +$1.42M 0.01% 502
2021
Q4 		– Sell
-11,076
Closed -$388K – 1060
2021
Q3 		$388K Sell
11,076
-12,246
-53% -$340K ﹤0.01% 868
2021
Q2 		$501K Buy
+23,322
New +$701K ﹤0.01% 760

Other funds holding AVIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vontobel Holding's AVIR Position: Q4 2023 in Review

Vontobel Holding sold out of Atea Pharmaceuticals (AVIR) in Q4 2023, closing a stake of 600,461 shares — an estimated $1.8M sold.

Vontobel Holding first reported a position in AVIR in Q2 2021 and held it in 6 quarters. The position peaked at $1.88M in Q2 2023. 108 funds tracked by Wall St. Rank hold AVIR as of Q4 2023.

  • Vontobel Holding reported no remaining Atea Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Vontobel Holding sold 600,461 Atea Pharmaceuticals shares in Q4 2023, an estimated $1.8M.
  • Vontobel Holding first reported a position in Atea Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • Vontobel Holding's Atea Pharmaceuticals position peaked at $1.88M in Q2 2023.
  • 108 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q4 2023.

Based on Vontobel Holding's 13F filing for Q4 2023, filed 30 Jan 2024.